标题
Microtubule destabilising agents: far more than just antimitotic anticancer drugs
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 83, Issue 2, Pages 255-268
出版商
Wiley
发表日期
2016-09-13
DOI
10.1111/bcp.13126
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105
- (2016) Darcy Bates et al. CANCER BIOLOGY & THERAPY
- The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4
- (2016) Min Su et al. Scientific Reports
- Death-associated protein kinase 2 mediates nocodazole-induced apoptosis through interaction with tubulin
- (2015) Kinuka Isshiki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hitting the brakes: targeting microtubule motors in cancer
- (2015) Gayathri Chandrasekaran et al. BRITISH JOURNAL OF CANCER
- Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemiain vivo
- (2015) Darcy J. P. Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2015/16: Overview
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
- (2015) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Eribulin Mesylate: Mechanism of Action of a Unique Microtubule-Targeting Agent
- (2015) N. F. Dybdal-Hargreaves et al. CLINICAL CANCER RESEARCH
- Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Jean-Yves Blay et al. LANCET ONCOLOGY
- Control of microtubule organization and dynamics: two ends in the limelight
- (2015) Anna Akhmanova et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
- (2015) Christopher Southan et al. NUCLEIC ACIDS RESEARCH
- Cellular responses to a prolonged delay in mitosis are determined by a DNA damage response controlled by Bcl-2 family proteins
- (2015) D. J. Colin et al. Open Biology
- Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function
- (2014) Jessica J. Field et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Antibody–drug conjugates—A new wave of cancer drugs
- (2014) Hervé Bouchard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole
- (2014) Federica Frezzato et al. BRITISH JOURNAL OF HAEMATOLOGY
- A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)
- (2014) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- DISRUPT: A randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane–platinum regimen as first-line therapy for metastatic non-small cell lung cancer
- (2014) Joachim von Pawel et al. LUNG CANCER
- Targeting Microtubules by Natural Agents for Cancer Therapy
- (2014) E. Mukhtar et al. MOLECULAR CANCER THERAPEUTICS
- Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells
- (2013) Cho Rong Han et al. APOPTOSIS
- Tubulin: an example of targeted chemotherapy
- (2013) Jenny Seligmann et al. Future Medicinal Chemistry
- Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737
- (2013) D. J. P. Bates et al. MOLECULAR CANCER THERAPEUTICS
- Eribulin: A Novel Cytotoxic Chemotherapy Agent
- (2012) Jessica N Preston et al. ANNALS OF PHARMACOTHERAPY
- Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells
- (2012) Wei-Hsin Chiu et al. BIOCHEMICAL PHARMACOLOGY
- Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine
- (2012) Jeffrey A. Silverman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inhibitors Targeting Mitosis: Tales of How Great Drugs against a Promising Target Were Brought Down by a Flawed Rationale
- (2012) E. Komlodi-Pasztor et al. CLINICAL CANCER RESEARCH
- Serial monitoring of human systemic and xenograft models of leukemia using a novel vascular disrupting agent
- (2012) M Benezra et al. LEUKEMIA
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
- (2012) Yan Lu et al. PHARMACEUTICAL RESEARCH
- c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells
- (2011) Juan Chen et al. ANTI-CANCER DRUGS
- Optimized anti-tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule
- (2011) H. Ehrhardt et al. BLOOD
- Vinblastine sensitizes leukemia cells to cyclin-dependent kinase inhibitors, inducing acute cell cycle phase-independent apoptosis
- (2011) Darcy J.P. Bates et al. CANCER BIOLOGY & THERAPY
- Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
- (2011) D. Rischin et al. CLINICAL CANCER RESEARCH
- Vascular Disrupting Agents (VDA) in Oncology: Advancing Towards New Therapeutic Paradigms in the Clinic
- (2011) Matthew A. Spear et al. CURRENT DRUG TARGETS
- Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
- (2011) Tina C. Albershardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties
- (2011) Bernard L. Flynn et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Chemosensitivity Nodes for Vinblastine through Small Interfering RNA High-Throughput Screens
- (2011) C. A. Kitchens et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Too early to say, “no targeting of mitosis!”
- (2011) Katsumi Kitagawa Nature Reviews Clinical Oncology
- Mitosis is not a key target of microtubule agents in patient tumors
- (2011) Edina Komlodi-Pasztor et al. Nature Reviews Clinical Oncology
- Microtubule targeting agents: from biophysics to proteomics
- (2010) D. Calligaris et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Vascular Targeting Agent Combretastatin-A4 and a Novel cis-Restricted -Lactam Analogue, CA-432, Induce Apoptosis in Human Chronic Myeloid Leukemia Cells and Ex Vivo Patient Samples Including Those Displaying Multidrug Resistance
- (2010) L. M. Greene et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- BNC105: A Novel Tubulin Polymerization Inhibitor That Selectively Disrupts Tumor Vasculature and Displays Single-Agent Antitumor Efficacy
- (2010) G. Kremmidiotis et al. MOLECULAR CANCER THERAPEUTICS
- Vinblastine Induces Acute, Cell Cycle Phase–Independent Apoptosis in Some Leukemias and Lymphomas and Can Induce Acute Apoptosis in Others when Mcl-1 Is Suppressed
- (2010) Bethany L. Salerni et al. MOLECULAR CANCER THERAPEUTICS
- A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents
- (2009) Peace Mabeta et al. ANGIOGENESIS
- Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells
- (2009) Bi-ke Zhu et al. ANTI-CANCER DRUGS
- Antivascular Actions of Microtubule-Binding Drugs
- (2009) E. L. Schwartz CLINICAL CANCER RESEARCH
- Kinesin-1 Regulates Microtubule Dynamics via a c-Jun N-terminal Kinase-dependent Mechanism
- (2009) Vanessa Daire et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Survivin counteracts the therapeutic effect of microtubule de-stabilizers by stabilizing tubulin polymers
- (2009) Chun Hei Antonio Cheung et al. Molecular Cancer
- Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs
- (2008) Karen E. Gascoigne et al. CANCER CELL
- Death through a tragedy: mitotic catastrophe
- (2008) H Vakifahmetoglu et al. CELL DEATH AND DIFFERENTIATION
- Distinct signaling pathways of microtubule inhibitors - vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively
- (2008) Sergey N. Kolomeichuk et al. FEBS Journal
- Key role for Bak activation and Bak-Bax interaction in the apoptotic response to vinblastine
- (2008) M. Upreti et al. MOLECULAR CANCER THERAPEUTICS
- Multisite Phosphorylation Regulates Bim Stability and Apoptotic Activity
- (2008) Anette Hübner et al. MOLECULAR CELL
- Potential Mechanisms of Resistance to Microtubule Inhibitors
- (2008) Maria Kavallaris et al. SEMINARS IN ONCOLOGY
- The contribution of c-Jun N-terminal kinase activation and subsequent Bcl-2 phosphorylation to apoptosis induction in human B-cells is dependent on the mode of action of specific stresses
- (2008) Donna E. Muscarella et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started